India, the world’s main provider of generic medicines, has lifted constraints on the export of 24 pharmaceutical ingredients and medicines created from them, the government said in an announcement.
It had imposed the caps last month as the coronavirus pandemic disrupted global supply networks. Paracetamol, a common ache reliever, and its formulations weren’t included in the list of drugs freed up for export.
It was not clear what prompted India to lift the constraints; however, Indian government sources had stated the bans had prompted intense pressure from the USA.
India had restricted the exports of 26 ingredients and medicines on March 3. Paracetamol and its formulations accounted for two objects on the original list.
The 26 active pharmaceutical elements and medicines accounted for 10% of all Indian pharmaceutical exports and include a number of antibiotics, such as tinidazole and erythromycin, the hormone progesterone and Vitamin B12.
India has put bans on the export of most diagnostic testing kits. And in recent weeks, it had banned the export of ventilators, masks and other protecting gear required by patients as well as medical employees.
Through the telephone call Saturday, Trump urged Modi to release supplies of the anti-malaria drug hydroxychloroquine, which is being examined as a possible therapy for patients with COVID-19 – the illness attributable to the coronavirus.